David R. King

David R. King

Direktör/Styrelseledamot på
Life Sciences Pennsylvania
Health Technology
Consumer Services
Commercial Services

Profil

David R.
King
is the founder of BioRexis Pharmaceutical Corp.
(founded in 2002) where he held the title of Chief Executive Officer.
He is currently working at Life Sciences Pennsylvania as Vice Chairman since 2013.
Mr. King has also held former positions as Chief Executive Officer at Principia Pharmaceutical Corp.
in 2000, Executive Chairman at Inotek Pharmaceuticals Corp., Chairman at Diasome Pharmaceuticals, Inc., Independent Vice Chairman at Atonarp, Inc., Director at Cephalon, Inc., 3-Dimensional Pharmaceuticals, Inc., Morphotek, Inc., and Xencor, Inc., and as a Corporate Officer at Morgan, Lewis & Bockius LLP.
He was also President at Delsys Pharmaceutical Corp.
in 2001 and served as a Venture Partner at Quaker Partners Management LP from 2008 to 2013.
Mr. King received his undergraduate degree from the University of Pennsylvania and his graduate degree from Harvard Law School.

Aktiva positioner av David R. King

FöretagPositionStart
Direktör/Styrelseledamot 2013-06-21

Tidigare kända positioner av David R. King

FöretagPositionSlut
Privat kapitalinvesterare 2013-03-01
Direktör/Styrelseledamot 2008-03-31
President 2001-09-01
Verkställande Direktör 2000-09-01
Direktör/Styrelseledamot -
Se detaljerna i David R. Kings erfarenhet

David R. Kings utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

56

Första gradens relationer

17

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag17

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Finance

Health Technology

Miscellaneous

Commercial Services

Finance

Consumer Services

Health Technology

  1. Börsen
  2. Insiders
  3. David R. King
40% rabatt: De bästa verktygen för prenumeranter för att identifiera morgondagens bästa investeringar!
d
:
:
TA DEL AV DET NU